Cargando…

Proliferating CD8(+) T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma

Background: tumor-infiltrating lymphocytes are prognostic in many human cancers. However, the prognostic value of lymphocytes infiltrating glioblastoma (GBM), and roles in tumor control or progression are unclear. We hypothesized that B and T cell density, and markers of their activity, proliferatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mauldin, Ileana S., Jo, Jasmin, Wages, Nolan A., Yogendran, Lalanthica V., Mahmutovic, Adela, Young, Samuel J., Lopes, Maria Beatriz, Slingluff, Craig L., Erickson, Loren D., Fadul, Camilo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699921/ https://www.ncbi.nlm.nih.gov/pubmed/34943886 http://dx.doi.org/10.3390/cells10123378

Ejemplares similares

Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma
por: Lynch, Kevin T, et al.
Publicado: (2021)

TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling
por: Mauldin, Ileana S, et al.
Publicado: (2014)

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
por: Melssen, Marit M, et al.
Publicado: (2015)

Defining the effects of age and gender on clinical immune response to cancer vaccination
por: Ramirez, Adriana, et al.
Publicado: (2014)

TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
por: Mauldin, Ileana S, et al.
Publicado: (2013)

Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas
por: Edmonds, Nicole L., et al.
Publicado: (2023)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163(+) myeloid cell infiltrates
por: Kwak, Minyoung, et al.
Publicado: (2021)

Barriers to immune cell infiltration in tumors
por: Melssen, Marit M, et al.
Publicado: (2023)

Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment
por: Pollack, Karlyn E, et al.
Publicado: (2020)

Decreased CD8(+) Lymphocytic Infiltration in Multifocal and Multicentric Glioblastomas
por: Wang, Run, et al.
Publicado: (2021)

5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients
por: Johnson, Kevin C., et al.
Publicado: (2016)

Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
por: Singh, Kirit, et al.
Publicado: (2021)

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
por: Molhoek, Kerrington R, et al.
Publicado: (2005)

A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma
por: Way, Gregory P., et al.
Publicado: (2017)

A web tool for designing and conducting phase I trials using the continual reassessment method
por: Wages, Nolan A., et al.
Publicado: (2018)

Impact of dose feasibility on the conduct of phase I trials of adoptive cell therapy
por: Bagley, Evan M., et al.
Publicado: (2021)

Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis
por: Schaefer , Jochen T, et al.
Publicado: (2010)

Melanoma brain metastasis mimicking cortical laminar necrosis
por: Marino, Alexandria C., et al.
Publicado: (2022)

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk
por: Salerno, Elise P., et al.
Publicado: (2016)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine
por: Tran, Christine A, et al.
Publicado: (2023)

Distribution of tumor-infiltrating immune cells in glioblastoma
por: Orrego, Enrique, et al.
Publicado: (2018)

Rapid Brainstem Infiltration of a Cerebellar Glioblastoma
por: De Jesus, Orlando, et al.
Publicado: (2022)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
por: Melssen, Marit M., et al.
Publicado: (2019)

Pericyte mediates the infiltration, migration, and polarization of macrophages by CD163/MCAM axis in glioblastoma
por: Zhang, Hao, et al.
Publicado: (2022)

MRI histogram analysis of tumor-infiltrating CD8+ T cell levels in patients with glioblastoma
por: Xue, Caiqiang, et al.
Publicado: (2023)

Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma
por: Zheng, Zong-Qing, et al.
Publicado: (2023)

Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma
por: Thiepold, Anna-Luisa, et al.
Publicado: (2015)

Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma
por: Rahimi Koshkaki, Hassan, et al.
Publicado: (2020)

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
por: Naghavian, Reza, et al.
Publicado: (2023)

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)
por: Vavolizza, Rick D, et al.
Publicado: (2022)

Bayesian Design for Identifying Cohort-Specific Optimal Dose Combinations Based on Multiple Endpoints: Application to a Phase I Trial in Non-Small Cell Lung Cancer
por: Horton, Bethany Jablonski, et al.
Publicado: (2021)

Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer
por: Wages, Nolan A., et al.
Publicado: (2022)

Local continual reassessment methods for dose finding and optimization in drug-combination trials
por: Zhang, Jingyi, et al.
Publicado: (2023)

Concurrent dose-finding of a novel cancer drug with and without a second agent
por: Wages, Nolan A., et al.
Publicado: (2023)

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma
por: Patel, Sapna P, et al.
Publicado: (2021)

Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma
por: Narang, Shivali, et al.
Publicado: (2017)

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme
por: Li, Hao, et al.
Publicado: (2021)

Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma
por: Wang, Zeyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kd9vprt46miql808gf4n83ga42